Gritstone bio, Inc.
DelistedCIK 1656634fmd_19YMSYE74E635H57DQTBJBGP41Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2016 to Jun 30, 2024, 31 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 1 | 4 | 4 | 48 | 20 | 16 |
| Research and development | 14 | 36 | 55 | 83 | 89 | 97 | 111 | 127 |
| Total operating expenses | 19 | 42 | 67 | 102 | 110 | 123 | 140 | 156 |
| Operating income | (19) | (42) | (66) | (98) | (106) | (75) | (120) | (140) |
| Interest expense | – | – | – | – | 0 | 0 | 1 | 4 |
| Net income | (19) | (41) | (65) | (94) | (105) | (75) | (120) | (138) |